KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Merck (MRK) Cash from Operations (2016 - 2026)

Merck has reported Cash from Operations over the past 18 years, most recently at 3918000000.0 for Q1 2026.

Quarterly Cash from Operations rose 56.72% to 3918000000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 17890000000.0 through Mar 2026, down 14.31% year-over-year, with the annual reading at 16472000000.0 for FY2025, 23.27% down from the prior year.
Cash from Operations was 3918000000.0 for Q1 2026 at Merck, up from 2857000000.0 in the prior quarter.
Over five years, Cash from Operations peaked at 9291000000.0 in Q3 2024 and troughed at 246000000.0 in Q4 2023.
The 5-year median for Cash from Operations is 3918000000.0 (2026), against an average of 4350529411.76.
Year-over-year, Cash from Operations tumbled 94.45% in 2023 and then surged 1302.44% in 2024.
A 5-year view of Cash from Operations shows it stood at 4430000000.0 in 2022, then tumbled by 94.45% to 246000000.0 in 2023, then surged by 1302.44% to 3450000000.0 in 2024, then dropped by 17.19% to 2857000000.0 in 2025, then soared by 37.14% to 3918000000.0 in 2026.
Per Business Quant, the three most recent readings for MRK's Cash from Operations are 3918000000.0 (Q1 2026), 2857000000.0 (Q4 2025), and 7822000000.0 (Q3 2025).